PT
Paul Tudor Jones II (Tudor Investment) disclosed decreased in Regeneron Pharmaceuticals Inc - US
Paul Tudor Jones II (Tudor Investment) filed a 13F change in Regeneron Pharmaceuticals Inc - US (75886F107) on 2026-05-15, covering period end 2026-03-31.
Action
Decreased
Capital
$59,433,451 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.